Short answer
Cross-linking aims to stop or slow the progression of keratoconus. Riboflavin (vitamin B2) is applied to the cornea and low-dose UV-A light is delivered, forming new bonds between corneal fibers and stiffening the cornea. It does not correct vision; it aims to preserve existing vision. In very advanced stages, a corneal transplant may be needed. The procedure takes about 30 to 45 minutes and the patient usually returns home the same day.
Keratoconus is a progressive eye disease in which the cornea thins and bulges forward into a cone shape. The cornea, which is normally dome-shaped, refracts light correctly and thus makes clear vision possible. In keratoconus, however, when the cornea thins and becomes pointed, light is refracted irregularly and visual quality deteriorates.
The disease usually begins in adolescence and young adulthood and can progress over time, leading to serious vision problems. Without early diagnosis and appropriate treatment, it can go as far as corneal transplantation in advanced stages.
What Is Cross-Linking (CXL) Treatment?
Cross-Linking (corneal collagen cross-linking) is a reliable, scientifically proven treatment method that aims to stop the progression of keratoconus.
The goal of treatment:
To increase the biomechanical strength of the cornea and to slow or stop progression.
How is the treatment performed?
-
Local anesthesia is given with eye drops.
-
In most methods, the outermost layer of the cornea (the epithelium) is removed (epithelium-off method). In some cases, the procedure can also be performed without removing the epithelium (epithelium-on method).
-
Riboflavin (vitamin B2) is dropped onto the cornea at set intervals.
-
A low dose of UV-A light is then applied to activate this vitamin.
-
The interaction between riboflavin and UV-A creates new bonds between the corneal fibers, stiffening the cornea.
⏱ The procedure takes about 30–45 minutes, and the patient can usually go home the same day.
Does Cross-Linking Correct Vision?
❌ CXL does not eliminate your glasses prescription or improve your current vision.
✅ The goal is to stop the progression of the disease and preserve current vision.
In other words, the treatment is performed less to improve visual quality than to prevent vision loss.
Who Is It Suitable For?
-
Patients with early and moderate-stage keratoconus
-
Cases that progress rapidly at a young age
-
Patients whose corneal thickness is suitable for treatment
In very advanced stages, if corneal thinning and distortion of shape are severe, a corneal transplant may be required.
Questions Patients Ask Most Often
Is CXL treatment painful?
No pain is felt during the procedure. Afterward, there may be stinging, watering and light sensitivity for a few days; these complaints are temporary.
How long is the recovery time?
The epithelial layer heals within a few days. Vision may be blurry in the first weeks but improves over time.
Is the treatment permanent?
In most patients, a single session is sufficient. However, in some cases, additional treatment may be needed if progression occurs.
Will I no longer need contact lenses or glasses?
CXL does not correct the refractive error. The need for glasses or lenses may continue, but because progression is halted, new vision loss is prevented.
Advantages of Cross-Linking Treatment
-
It stops the progression of keratoconus.
-
It prevents vision loss.
-
It reduces or delays the need for a corneal transplant.
-
It is a safe, scientific and long-established method.
The Importance of Early Diagnosis
If keratoconus is diagnosed in its early stage, treatment is much more effective.
Patients whose glasses prescription changes frequently or who have blurred vision, especially young patients, must have an eye examination.
Routine eye check-ups are of great importance for catching the disease early and preserving vision.
Conclusion
Keratoconus is a progressive disease, but it can be brought under control with early diagnosis and Cross-Linking treatment.
This method helps stop the progression of the disease without loss of vision and reduces the need for a corneal transplant.
If you have been diagnosed with keratoconus, it is very important to discuss the process with your doctor without delay.
Scientific references
- Hafezi F, Kling S, Hafezi NL, et al.. Corneal cross-linking. Prog Retin Eye Res. 2025. PMID: 39681212
- Belin MW, Jang HS, Borgstrom M. Keratoconus: Diagnosis and Staging. Cornea. 2022. PMID: 34116536
- Santodomingo-Rubido J, Carracedo G, Suzaki A, et al.. Keratoconus: An updated review. Cont Lens Anterior Eye. 2022. PMID: 34991971



